Avenues of Reimbursement

No-fault insurance systems across different states employ varying methodologies for determining reasonable reimbursement rates for medical services. In New York, healthcare providers can seek payment according to prescribed fee schedules established by regulation, or alternatively argue that charges are reasonable and customary within the community. Florida’s Personal Injury Protection (PIP) system similarly recognizes multiple approaches to establishing reasonable charges, creating strategic choices for insurance carriers defending against claims for medical reimbursement.

The evolution of reimbursement methodologies reflects ongoing tension between healthcare providers seeking full compensation and insurance carriers attempting to control costs. Fee schedules offer certainty and administrative efficiency, establishing fixed maximum reimbursement rates based on procedure codes. Reasonable and customary charge analysis, conversely, requires fact-intensive inquiries into prevailing community rates, creating more flexibility but also more litigation.

A critical development in reimbursement disputes involves the increasing sophistication of expert testimony regarding reasonable charges. Insurance carriers defending medical necessity or reasonableness challenges must present expert opinions that satisfy rigorous evidentiary standards under Daubert and its progeny. The expert cannot simply opine conclusorily that charges are unreasonable; the expert must articulate a reliable methodology, apply accepted principles, and explain the factual basis for conclusions.

Case Background

STATE FARM MUTUAL AUTOMOBILE INSURANCE COMPANY, vs ALL X-RAY DIAGNOSTIC SERVICES, CORP., A/A/O PEDRO RIOS, 3D21-0063 (Fla 3d DCA 2022) arose from a Florida PIP dispute where State Farm challenged the reasonableness of charges submitted by All X-Ray Diagnostic Services. State Farm presented expert testimony from Dr. Dauer, who opined that the charges exceeded reasonable reimbursement rates based on multiple factors including Medicare Part B fee schedules, community reimbursement patterns, and statutory considerations under Florida’s PIP statute.

All X-Ray challenged Dr. Dauer’s testimony as inadmissible, arguing that reliance on Medicare fee schedules as a benchmark for reasonableness constituted “pure opinion” evidence lacking proper foundation. The provider contended that Medicare reimbursement rates, which are notoriously lower than private insurance rates, do not reliably indicate reasonable charges in the commercial market. The trial court admitted Dr. Dauer’s testimony and rendered judgment for State Farm, prompting All X-Ray’s appeal.

The Third District Court of Appeal examined whether Dr. Dauer’s methodology satisfied Florida’s evidentiary requirements for expert testimony, particularly whether reference to Medicare fee schedules, combined with other factors, provided a sufficiently reliable basis for opinions on reasonable charges.

Jason Tenenbaum’s Analysis

There are two avenues of reimbursement – the fee schedule and R and C. The prior precedent used to be simply that you chose one and that is it. The Courts have held that you can play with both mechanisms of reimbursement, of course using as an expert to achieve the more advantageous result for the carrier

“However, even if Dr. Dauer’s affidavit did in fact rely entirely on the Medicare Part B fee schedules as the basis for reasonableness (which it did not), the affidavit was not “pure opinion” evidence because it resulted from the application of reliable principles and methods to the facts of the case. The affidavit addresses Dr. , as well as the underlying data Dr. Dauer reviewed. The affidavit explains which information influenced Dr. Dauer’s opinion regarding reasonableness and how, and also individually addresses each of the Daubert factors in relation to the specific methodology used.

Finally, the affidavit explains the rationale behind the methodology used and why it was reliable, and also explains why Dr.

Legal Significance

The Third District’s decision validates a hybrid approach to establishing reasonable charges in PIP litigation. Insurance carriers need not choose exclusively between fee schedule analysis and reasonable and customary charge analysis. Instead, experts may consider multiple data sources, including Medicare fee schedules, prevailing community rates, and statutory factors, synthesizing these inputs into comprehensive opinions on reasonableness.

This holding recognizes the reality that Medicare reimbursement rates, while lower than commercial rates, provide valuable benchmarks for evaluating charge reasonableness. Medicare fee schedules reflect extensive government analysis of appropriate resource-based relative value scales for medical procedures. While Medicare rates alone may not establish reasonableness in the private market, they constitute relevant data points that experts may consider alongside other factors.

The decision also clarifies Daubert standards for reimbursement expert testimony. Experts must articulate their qualifications, explain their methodology, identify the data reviewed, and demonstrate how their conclusions flow from application of reliable principles to case-specific facts. However, experts need not limit themselves to a single data source or methodology. Reasonable minds may differ on appropriate benchmarks for charge reasonableness, and courts will admit expert testimony employing various methodologies so long as the expert adequately explains and justifies the approach.

Practical Implications

For insurance carriers defending reasonableness challenges in no-fault and PIP litigation, State Farm v All X-Ray provides valuable guidance on expert opinion development. Carriers should retain experts who can articulate comprehensive, multi-factor analyses of charge reasonableness. The expert affidavit or testimony should address qualifications, methodology, data sources considered, application of statutory factors, and explanation of conclusions.

Experts should avoid relying solely on Medicare fee schedules, as exclusive reliance on government rates that are systematically lower than commercial rates invites attacks on methodology. Instead, experts should reference Medicare data as one factor among several, including community rate surveys, commercial fee schedule comparisons, and the expert’s personal knowledge of prevailing rates based on professional experience.

Healthcare providers challenging reimbursement denials must scrutinize defense experts’ methodologies carefully. Providers should demand complete disclosure of the data the expert reviewed, the specific calculations performed, and the relative weight accorded to different factors. If the expert’s opinion rests primarily on Medicare rates without adequate consideration of commercial market rates, providers can argue the methodology is unreliable.

Providers should also present contrary expert testimony establishing the reasonableness of their charges through commercial market data, community surveys, and documentation of actual reimbursement rates received from other carriers. Expert opinions on reasonableness become battles of methodology, and prevailing often requires demonstrating that the provider’s approach better reflects actual market conditions than the carrier’s Medicare-centric analysis.

The decision also has strategic implications for selecting between fee schedule and reasonable and customary charge reimbursement paths. As counsel observes, parties previously believed they must choose one approach or the other. The State Farm decision confirms that flexible, multi-factor approaches combining elements of both methodologies are permissible, giving experts broader latitude in constructing persuasive opinions.

Related Articles

• Understanding the CPLR 3212(g) paradigm for summary judgment motions
• Critical timing rules for summary judgment motions under CPLR 3212(a)
• No-fault verification requirements and compliance standards
• Regulatory amendments and their impact on no-fault practice
• New York No-Fault Insurance Law